Product Details for: Epysqli
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
300MG/30ML (10MG/ML)
Single-Dose Vial
351(k) Interchangeable
Epysqli
Rx
Proper Name
eculizumab-aagh
eculizumab-aagh
Reference Product Proper Name
eculizumab
eculizumab
Reference Product Properietary Name
Soliris
Soliris
BLA Number
761340
761340
Applicant
Samsung Bioepis Co., Ltd.
Samsung Bioepis Co., Ltd.
Original Approval Date
July 19, 2024
July 19, 2024
Date of First Licensure